Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1380, 2003-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Abciximab: benefits for some in ACS
Inpharma, Vol. 1, Iss. 1535, 2006-01 ,pp. :
Women with ACS benefit from early invasive management
Inpharma, Vol. 1, Iss. 1370, 2003-01 ,pp. :
Abciximab disappoints in ACS without early revascularisation
Inpharma, Vol. 1, Iss. 1257, 2000-01 ,pp. :
Abciximab beneficial in younger patients with ACS undergoing PCI
Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. :
A Risk-Benefit Assessment of Abciximab in Angioplasty
By Kleiman N.S.
Drug Safety, Vol. 20, Iss. 1, 1999-01 ,pp. :